Mulligan Margaret Jean 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Oct 5, 2010
Insider Transaction Report
Form 4
Mulligan Margaret Jean
EVP, CFO
Transactions
- Award
Restricted Share Units
2010-10-04+24→ 6,687 totalFrom: 2012-02-25Exp: 2012-02-25→ Common Stock, no par value (24 underlying) - Award
Restricted Share Units
2010-10-04+187→ 51,329 totalFrom: 2014-08-05Exp: 2014-08-05→ Common Stock, no par value (187 underlying) - Award
Restricted Share Units
2010-10-04+23→ 6,337 totalFrom: 2013-02-17Exp: 2013-02-17→ Common Stock, no par value (23 underlying)
Footnotes (2)
- [F1]Each Restricted Share Unit represents a contingent right to receive one share of Common Stock, no par value, of Valeant Pharmaceuticals International, Inc. (the "Common Stock").
- [F2]Represents dividend equivalents accrued on Restricted Share Units as a result of a dividend paid on the Common Stock on October 4, 2010.